A New Momentum for Renal Denervation: 2023 ESH Guidelines
In light of the recent ESC clinical consensus statement on Renal Denervation (RDN), a significant development has occurred in the management of hypertension. The European Society of Hypertension (ESH) has officially endorsed Renal Denervation as a recommended treatment for hypertension. This marks a pivotal moment in the field of hypertension management.
This broadcast will feature a compelling discussion between two distinguished experts, Dr Joost Daemen (Erasmus University Medical Center, Rotterdam, NL) and Prof Dagmara Hering (Medical University of Gdańsk, Gdańsk, PL). They will provide invaluable insights into how these new guidelines impact their approach to patient selection and the adjustments that should be made in the patient care pathway for hypertension treatment. Gain a deeper understanding of the evolving landscape of hypertension management in this engaging conversation.
This programme is supported by
- Learn about the 2023 ESH guidelines about Renal Denervation
- Deep dive into class of recommendation and level of evidence
- Overview of Ultrasound RDN clinical evidence
- Understand recommended patient pathways and hear case discussions.
- Interventional Cardiologist
- Hypertension Specialist
- General Physician
- Internal medicine
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. At present, he is participating in cathlab-related activities including complex PCI like the use of left ventricular assist devices, intracoronary imaging, cardiac physiology, and structural heart interventions including TAVI, Mitraclip, and renal sympathetic denervation.
Prof Dagmara Hering is a medical scientist and clinical specialist in internal medicine, a specialist in hypertension, and a cardiologist at the Medical University of Gdansk, Gdansk, PL.
She is also a Professorial Fellow at Baker IDI Heart and Diabetes Institute, Melbourne, AU and a Clinical Expert of the European Society of Hypertension, and a Fellow of the European Society of Cardiology.
Her clinical research has been focused on the role of the sympathetic nervous system in hypertension, and cardiovascular and renal diseases, and has substantially contributed to the understanding of the efficacy of device-based therapies including renal denervation.